Sutent (sunitinib malate)

pCPA File Number: 20751
Negotiation Status:
Concluded with an LOI
Indication(s):
Pancreatic Neuroendocrine Tumors
Sponsor/Manufacturer:
Pfizer Canada ULC
CADTH Project Number:
pCODR 10004
pCPA Engagement Letter Issued:
Negotiation Process Concluded: